
Viebeg
AI-driven procurement platform for African healthcare supplies.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor | €0.0 | round |
N/A | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
* | N/A | - | |
Total Funding | 000k |
Related Content
Viebeg Technologies is a data-driven procurement platform focused on optimizing the medical supply chain in East and Central Africa. Founded in 2018 by CEO Tobias Reiter and CCO Alex Musyoka, the company aims to make medical supplies and equipment more accessible and affordable. Reiter, an AI enthusiast from Austria with a background in business administration and building AI platforms, met Musyoka, a Kenyan native with over 12 years of experience in the medical supplies industry. They identified significant inefficiencies and shortages in the healthcare procurement process across the region, which led them to establish Viebeg.
The company operates a B2B platform, VieProcure, that connects healthcare providers directly with manufacturers, aiming to reduce costs by up to 40% by eliminating middlemen. This AI-powered platform manages the entire logistics process, including shipping, warehousing, last-mile distribution, and inventory management, to prevent stockouts and ensure providers have the necessary supplies. Viebeg serves a client base of over 1,000 hospitals, clinics, and pharmacies in countries including Rwanda, Kenya, Burundi, and the Democratic Republic of the Congo.
Viebeg's business model generates revenue through direct sales on its platform and by offering embedded financing options like buy-now-pay-later to clients, which addresses cash flow challenges common in the market. Additionally, the company monetizes the market insights and real-time purchasing data gathered by its platform, providing this information to global health organizations and manufacturers. The company has secured investments from firms such as Johnson & Johnson, Sanofi, Beyond Capital Ventures, and the Rwanda Innovation Fund.